1Centre of Research Excellence in Nutrition and Metabolism,Institute for Medical Research,University of Belgrade,Tadeusa Koscuska 1,11000 Belgrade,Serbia.
2School of Dietetics and Human Nutrition,McGill University,Macdonald Campus,Ste Anne-de-Bellevue,Québec,Canada.
Public Health Nutr. 2017 Jul;20(10):1825-1835. doi: 10.1017/S1368980016000409. Epub 2016 Apr 18.
The objective of the present study was to determine if vitamin D intake and status are associated with pre-eclampsia in a country without a vitamin D fortification policy.
A case-control study of pregnancies with (case) and without (control) pre-eclampsia was conducted from January to April when UVB is minimal. Maternal and cord blood obtained at delivery were measured for plasma 25-hydroxycholecalciferol (25-OH-D3), 3-epimer of 25-OH-D3 (3-epi-25-OH-D3) and 24,25-dihydroxycholecalciferol (24,25-(OH)2D3) by LC-MS/MS and maternal 1,25-dihydroxyvitamin D (1,25-(OH)2D). Differences between groups were tested with ANOVA and Bonferroni post hoc tests (P<0·05).
Clinical Center of Serbia.
Pregnant women with and without pre-eclampsia (n 60) and their infants.
Exogenous vitamin D intake (0·95-16·25 µg/d (38-650 IU/d)) was not significantly different between groups. Women with pre-eclampsia delivered infants at an earlier gestational age and had significantly lower mean total plasma 25-hydroxyvitamin D (25-OH-D; case: 11·2 (sd 5·1); control: 16·1 (sd 5·7) ng/ml; P=0·0006), 25-OH-D3 (case: 10·0 (sd 4·9); control: 14·2 (sd 5·8) ng/ml; P=0·002), 3-epi-25-OH-D3 (case: 0·5 (sd 0·2); control: 0·7 (sd 0·2) ng/ml; P=0·0007) and 1,25-(OH)2D (case: 56·5 (sd 26·6); control: 81·0 (sd 25·7) pg/ml; P=0·018), while 24,25-(OH)2D3 was not different between groups. Infants did not differ in total plasma 25-OH-D, 25-OH-D3, 3-epi-25-OH-D3 and 24,25-(OH)2D3, but the mean proportion of 3-epi-25-OH-D3 was higher in the infant case group (case: 7·9 (sd 1·1); control: 7·0 (sd 1·4) % of total 25-OH-D3; P=0·005).
A high prevalence of vitamin D deficiency, as defined by plasma 25-OH-D<12 ng/ml, was observed in 47 % of all mothers and 77 % of all infants. These data underscore the need for prenatal vitamin D supplementation and a food fortification policy in Serbia.
本研究旨在确定在一个没有维生素 D 强化政策的国家,维生素 D 摄入和状态是否与子痫前期有关。
对 1 月至 4 月(UVB 最少时)出现子痫前期(病例)和未出现子痫前期(对照)的妊娠进行病例对照研究。分娩时采集母血和脐血,采用 LC-MS/MS 法测定血浆 25-羟胆钙化醇(25-OH-D3)、3-差向 25-羟胆钙化醇(3-epi-25-OH-D3)和 24,25-二羟胆钙化醇(24,25-(OH)2D3),并测定母 1,25-二羟胆钙化醇(1,25-(OH)2D)。采用方差分析和 Bonferroni 事后检验(P<0·05)比较组间差异。
塞尔维亚临床中心。
患有和未患有子痫前期的孕妇(n=60)及其婴儿。
两组间外源性维生素 D 摄入量(0·95-16·25 µg/d(38-650 IU/d))无显著差异。患有子痫前期的孕妇分娩时胎龄更小,总血浆 25-羟胆钙化醇(25-OH-D;病例:11·2(sd 5·1);对照:16·1(sd 5·7)ng/ml;P=0·0006)、25-OH-D3(病例:10·0(sd 4·9);对照:14·2(sd 5·8)ng/ml;P=0·002)、3-epi-25-OH-D3(病例:0·5(sd 0·2);对照:0·7(sd 0·2)ng/ml;P=0·0007)和 1,25-(OH)2D(病例:56·5(sd 26·6);对照:81·0(sd 25·7)pg/ml;P=0·018)水平显著较低,而 24,25-(OH)2D3 两组间无差异。婴儿总血浆 25-OH-D、25-OH-D3、3-epi-25-OH-D3 和 24,25-(OH)2D3 水平无差异,但病例组婴儿的 3-epi-25-OH-D3 比例较高(病例:7·9(sd 1·1);对照:7·0(sd 1·4)%的总 25-OH-D3;P=0·005)。
所有母亲中有 47%、所有婴儿中有 77%存在维生素 D 缺乏(定义为血浆 25-OH-D<12ng/ml),这一数据突显了塞尔维亚产前补充维生素 D 和食品强化政策的必要性。